Suppr超能文献

分化型甲状腺癌的显微镜下切缘阳性并非局部复发的独立预测因素。

Microscopic Positive Margins in Differentiated Thyroid Cancer Is Not an Independent Predictor of Local Failure.

作者信息

Wang Laura Y, Ghossein Ronald, Palmer Frank L, Nixon Iain J, Tuttle R Michael, Shaha Ashok R, Shah Jatin P, Patel Snehal G, Ganly Ian

机构信息

1 Department of Surgery, Head and Neck Service, Memorial Sloan Kettering Cancer Center , New York, New York.

2 Department of Pathology, Memorial Sloan Kettering Cancer Center , New York, New York.

出版信息

Thyroid. 2015 Sep;25(9):993-8. doi: 10.1089/thy.2015.0141. Epub 2015 Jul 30.

Abstract

BACKGROUND

In contrast to other head and neck cancers, the impact of histological thyroid specimen margin status in differentiated thyroid cancer (DTC) is not well understood. The aim of this study was to investigate the prognostic value of margin status on local recurrence in DTC.

METHOD

The records of 3664 consecutive patients treated surgically for DTC between 1986 and 2010 were identified from an institutional database. Patients with less than total thyroidectomy, unresectable or gross residual disease, or M1 disease at presentation and those with unknown pathological margin status were excluded from analysis. In total, 2616 patients were included in the study; 2348 patients (90%) had negative margins and 268 patients (10%) had positive margins. Microscopic positive margin status was defined as tumor present at the specimen's edge on pathological analysis. Patient, tumor, and treatment characteristics were compared by Pearson's chi-squared test. Local recurrence free survival (LRFS) was calculated for each group using the Kaplan Meier method.

RESULTS

The median age of the cohort was 48 years (range 7-91 years) and the median follow-up was 50 months (range 1-330 months). Age, sex, and histology types were similar between groups. As expected, patients who had positive margins were more likely to have larger tumors (p<0.001), extrathyroidal extension (ETE) (p<0.001), multicentric disease (p<0.001), or nodal disease (p<0.001) and were more likely to receive adjuvant radioactive iodine therapy (p<0.001) as well as external beam radiotherapy (p<0.001). The LRFS at 5 years for patients with positive margins status was slightly poorer compared with patients with negative margins (98.9% vs. 99.5%, p=0.018). Twelve patients developed local recurrence-8/2348 (0.34%) patients with negative margins and 4/263 (1.52%) patients with positive margins. Univariate predictors of LRFS were sex (p=0.006), gross ETE (<0.001), and positive margins (p=0.018). However, when controlling for presence of gross ETE on multivariate analysis, microscopic positive margin status was not an independent predictor of LRFS (p=0.193).

CONCLUSION

Patients with resectable, M0 disease that undergo total thyroidectomy have an excellent five year LRFS of 99.4%. Microscopic positive margin status was not a significant predictor for local failure after adjusting for ETE or pathological tumor (pT) stage.

摘要

背景

与其他头颈癌不同,组织学甲状腺标本切缘状态在分化型甲状腺癌(DTC)中的影响尚未得到充分理解。本研究的目的是探讨切缘状态对DTC局部复发的预后价值。

方法

从机构数据库中识别出1986年至2010年间连续接受手术治疗的3664例DTC患者的记录。未行全甲状腺切除术、不可切除或肉眼残留疾病、就诊时为M1期疾病以及病理切缘状态未知的患者被排除在分析之外。总共有2616例患者纳入研究;2348例患者(90%)切缘阴性,268例患者(10%)切缘阳性。显微镜下切缘阳性状态定义为病理分析时标本边缘存在肿瘤。通过Pearson卡方检验比较患者、肿瘤和治疗特征。使用Kaplan-Meier方法计算每组的无局部复发生存期(LRFS)。

结果

队列的中位年龄为48岁(范围7 - 91岁),中位随访时间为50个月(范围1 - 330个月)。两组间年龄、性别和组织学类型相似。正如预期的那样,切缘阳性的患者更有可能患有更大的肿瘤(p<0.001)、甲状腺外侵犯(ETE)(p<0.001)、多中心疾病(p<0.001)或淋巴结疾病(p<0.001),并且更有可能接受辅助放射性碘治疗(p<0.001)以及外照射放疗(p<0.001)。切缘阳性状态患者的5年LRFS与切缘阴性患者相比略差(98.9%对99.5%,p = 0.018)。12例患者发生局部复发 - 切缘阴性的2348例患者中有8例(0.34%),切缘阳性的263例患者中有4例(|1.52%)。LRFS的单因素预测因素为性别(p = 0.006)、肉眼可见的ETE(<0.001)和切缘阳性(p = 0.018)。然而,在多因素分析中控制肉眼可见的ETE存在情况后,显微镜下切缘阳性状态不是LRFS的独立预测因素(p = 0.193)。

结论

接受全甲状腺切除术的可切除M0期疾病患者的5年LRFS极佳,为99.4%。在调整ETE或病理肿瘤(pT)分期后,显微镜下切缘阳性状态不是局部失败的显著预测因素。

相似文献

7
Management and outcome of recurrent well-differentiated thyroid carcinoma.复发性高分化甲状腺癌的管理与预后
Arch Otolaryngol Head Neck Surg. 2004 Jul;130(7):819-24. doi: 10.1001/archotol.130.7.819.
8
Operative management of locally advanced, differentiated thyroid cancer.局部晚期分化型甲状腺癌的手术治疗
Surgery. 2016 Sep;160(3):738-46. doi: 10.1016/j.surg.2016.04.027. Epub 2016 Jun 11.

引用本文的文献

3
A comparative analysis of treatment efficacy in intermediate-risk thyroid cancer.中危甲状腺癌治疗效果的对比分析。
Eur Arch Otorhinolaryngol. 2023 May;280(5):2525-2533. doi: 10.1007/s00405-023-07832-1. Epub 2023 Jan 18.
7
Hemithyroidectomy for Thyroid Cancer: A Review.甲状腺癌的甲状腺次全切除术:综述。
Medicina (Kaunas). 2020 Nov 3;56(11):586. doi: 10.3390/medicina56110586.

本文引用的文献

1
Surgical margins in head and neck squamous cell carcinoma: what is 'close'?头颈部鳞状细胞癌的手术切缘:何为“近切缘”?
Eur Arch Otorhinolaryngol. 2013 Sep;270(10):2603-9. doi: 10.1007/s00405-012-2317-8. Epub 2012 Dec 28.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验